# AZD8075 Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Oral Doses of AZD8075 in Healthy Male Volunteers

> **NCT00829127** · PHASE1 · WITHDRAWN · sponsor: **AstraZeneca** · enrollment: 27 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** AZD8075
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00829127
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-01
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 27 (ESTIMATED)
- **Why stopped:** Due to termination of study D3801C00001, due to reports of turbid urine.
- **Last updated:** 2011-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00829127

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00829127, "AZD8075 Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Oral Doses of AZD8075 in Healthy Male Volunteers". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00829127. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*